Home » Pharma & Healthcare » World Biosimilar Drug Market by Player, Region, Type, Application and Sales Channel, Forecast 2022-2030

World Biosimilar Drug Market by Player, Region, Type, Application and Sales Channel, Forecast 2022-2030

  119 Pages     Pharma & Healthcare  

Available Formats      

Report ID: 91912
Published By: MAResearch

Summary

Global Biosimilar Drug Market was valued at $XX million in 2021, and research analysts predict the global market size will reach $XX million by the end of 2030, growing at a CAGR of XX% between 2022 and 2030.

Scope of Report

This report studies the Biosimilar Drug market, covering market size for segment by type (Injection, Tablets, etc.), by application (Ankylosing Spondylitis, Tumor, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Roche, Amgen, AbbVie, Sanofi-Aventis, Johnson & Johnson, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).

This report provides detailed historical analysis of global market for Biosimilar Drug from 2016-2021, and provides extensive market forecasts from 2022-2030 by region/country and subsectors. It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the Biosimilar Drug market.

COVID-19 Impact

Moreover, the impact of COVID-19 is also concerned. Since outbreak in December 2019, the COVID-19 virus has spread to all around the world and caused huge losses of lives and economy, and the global manufacturing, tourism and financial markets have been hit hard, while the online market/industry increase. Fortunately, with the development of vaccine and other effort by global governments and organizations, the negative impact of COVID-19 is expected to subside and the global economy is expected to recover.

This research covers COVID-19 impacts on the upstream, midstream and downstream industries. Moreover, this research provides an in-depth market evaluation by highlighting information on various aspects covering market dynamics like drivers, barriers, opportunities, threats, and industry news & trends. In the end, this report also provides in-depth analysis and professional advices on how to face the post COIVD-19 period.

Research Methodology

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Leading players of Biosimilar Drug including:

  • Roche
  • Amgen
  • AbbVie
  • Sanofi-Aventis
  • Johnson & Johnson
  • Pfizer
  • Novo Nordisk
  • Eli Lilly
  • Novartis
  • Merck
  • 3sbio
  • Changchun High Tech
  • CP Guojian
  • Biotech
  • Gelgen
  • Innovent
  • Dong Bao
  • Ganlee

Market split by Type, can be divided into:

  • Injection
  • Tablets
  • Other Types

Market split by Application, can be divided into:

  • Ankylosing Spondylitis
  • Tumor
  • Rheumatoid Arthrtis
  • Cardiovascular
  • Other Application

Market split by Sales Channel, can be divided into:

  • Direct Channel
  • Distribution Channel

Market segment by Region/Country including:

  • North America (United States, Canada and Mexico)
  • Europe (Germany, UK, France, Italy, Russia and Spain etc.)
  • Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
  • South America (Brazil, Argentina and Colombia etc.)
  • Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)

If you have any special requirements, please let us know and we will offer you the report as you want.

Table Of Contents

Chapter 1 Biosimilar Drug Market Overview

1.1 Biosimilar Drug Definition

1.2 Global Biosimilar Drug Market Size Status and Outlook (2016-2030)

1.3 Global Biosimilar Drug Market Size Comparison by Region (2016-2030)

1.4 Global Biosimilar Drug Market Size Comparison by Type (2016-2030)

1.5 Global Biosimilar Drug Market Size Comparison by Application (2016-2030)

1.6 Global Biosimilar Drug Market Size Comparison by Sales Channel (2016-2030)

1.7 Biosimilar Drug Market Dynamics (COVID-19 Impacts)

1.7.1 Market Drivers/Opportunities

1.7.2 Market Challenges/Risks

1.7.3 Market News (Mergers/Acquisitions/Expansion)

1.7.4 COVID-19 Impacts

1.7.5 Post-Strategies of COVID-19

Chapter 2 Biosimilar Drug Market Segment Analysis by Player

2.1 Global Biosimilar Drug Sales and Market Share by Player (2019-2021)

2.2 Global Biosimilar Drug Revenue and Market Share by Player (2019-2021)

2.3 Global Biosimilar Drug Average Price by Player (2019-2021)

2.4 Players Competition Situation & Trends

2.5 Conclusion of Segment by Player

Chapter 3 Biosimilar Drug Market Segment Analysis by Type

3.1 Global Biosimilar Drug Market by Type

3.1.1 Injection

3.1.2 Tablets

3.1.3 Other Types

3.2 Global Biosimilar Drug Sales and Market Share by Type (2016-2021)

3.3 Global Biosimilar Drug Revenue and Market Share by Type (2016-2021)

3.4 Global Biosimilar Drug Average Price by Type (2016-2021)

3.5 Leading Players of Biosimilar Drug by Type in 2021

3.6 Conclusion of Segment by Type

Chapter 4 Biosimilar Drug Market Segment Analysis by Application

4.1 Global Biosimilar Drug Market by Application

4.1.1 Ankylosing Spondylitis

4.1.2 Tumor

4.1.3 Rheumatoid Arthrtis

4.1.4 Cardiovascular

4.1.5 Other Application

4.2 Global Biosimilar Drug Revenue and Market Share by Application (2016-2021)

4.3 Leading Consumers of Biosimilar Drug by Application in 2021

4.4 Conclusion of Segment by Application

Chapter 5 Biosimilar Drug Market Segment Analysis by Sales Channel

5.1 Global Biosimilar Drug Market by Sales Channel

5.1.1 Direct Channel

5.1.2 Distribution Channel

5.2 Global Biosimilar Drug Revenue and Market Share by Sales Channel (2016-2021)

5.3 Leading Distributors/Dealers of Biosimilar Drug by Sales Channel in 2021

5.4 Conclusion of Segment by Sales Channel

Chapter 6 Biosimilar Drug Market Segment Analysis by Region

6.1 Global Biosimilar Drug Market Size and CAGR by Region (2016-2030)

6.2 Global Biosimilar Drug Sales and Market Share by Region (2016-2021)

6.3 Global Biosimilar Drug Revenue and Market Share by Region (2016-2021)

6.4 North America

6.4.1 North America Market by Country

6.4.2 North America Biosimilar Drug Market Share by Type

6.4.3 North America Biosimilar Drug Market Share by Application

6.4.4 United States

6.4.5 Canada

6.4.6 Mexico

6.5 Europe

6.5.1 Europe Market by Country

6.5.2 Europe Biosimilar Drug Market Share by Type

6.5.3 Europe Biosimilar Drug Market Share by Application

6.5.4 Germany

6.5.5 UK

6.5.6 France

6.5.7 Italy

6.5.8 Russia

6.5.9 Spain

6.6 Asia-Pacific

6.6.1 Asia-Pacific Market by Country

6.6.2 Asia-Pacific Biosimilar Drug Market Share by Type

6.6.3 Asia-Pacific Biosimilar Drug Market Share by Application

6.6.4 China

6.6.5 Japan

6.6.6 Korea

6.6.7 India

6.6.8 Southeast Asia

6.6.9 Australia

6.7 South America

6.7.1 South America Market by Country

6.7.2 South America Biosimilar Drug Market Share by Type

6.7.3 South America Biosimilar Drug Market Share by Application

6.7.4 Brazil

6.7.5 Argentina

6.7.6 Colombia

6.8 Middle East & Africa

6.8.1 Middle East & Africa Market by Country

6.8.2 Middle East & Africa Biosimilar Drug Market Share by Type

6.8.3 Middle East & Africa Biosimilar Drug Market Share by Application

6.8.4 UAE

6.8.5 Saudi Arabia

6.8.6 South Africa

6.9 Conclusion of Segment by Region

Chapter 7 Profile of Leading Biosimilar Drug Players

7.1 Roche

7.1.1 Company Snapshot

7.1.2 Product/Service Offered

7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

7.2 Amgen

7.3 AbbVie

7.4 Sanofi-Aventis

7.5 Johnson & Johnson

7.6 Pfizer

7.7 Novo Nordisk

7.8 Eli Lilly

7.9 Novartis

7.10 Merck

7.11 3sbio

7.12 Changchun High Tech

7.13 CP Guojian

7.14 Biotech

7.15 Gelgen

7.16 Innovent

7.17 Dong Bao

7.18 Ganlee

Chapter 8 Upstream and Downstream Analysis of Biosimilar Drug

8.1 Industrial Chain of Biosimilar Drug

8.2 Upstream of Biosimilar Drug

8.3 Downstream of Biosimilar Drug

Chapter 9 Development Trend of Biosimilar Drug (2022-2030)

9.1 Global Biosimilar Drug Market Size (Sales and Revenue) Forecast (2022-2030)

9.2 Global Biosimilar Drug Market Size and CAGR Forecast by Region (2022-2030)

9.3 Global Biosimilar Drug Market Size and CAGR Forecast by Type (2022-2030)

9.4 Global Biosimilar Drug Market Size and CAGR Forecast by Application (2022-2030)

9.5 Global Biosimilar Drug Market Size and CAGR Forecast by Sales Channel (2022-2030)

Chapter 10 Appendix

10.1 Research Methodology

10.2 Data Sources

10.3 Disclaimer

10.4 Analysts Certification

If you have any special requirements, please let us know and we will offer you the report as you want.

Fact & Figures

Figure Biosimilar Drug Example

Figure Global Biosimilar Drug Revenue (Million $) Status and Outlook (2016-2030)

Figure Global Biosimilar Drug Revenue (Million $) Comparison by Region (2016-2030)

Figure Global Biosimilar Drug Revenue (Million $) Comparison by Type (2016-2030)

Figure Global Biosimilar Drug Revenue (Million $) Comparison by Application (2016-2030)

Figure Global Biosimilar Drug Revenue (Million $) Comparison by Sales Channel (2016-2030)

Table Global Biosimilar Drug Sales by Player (2019-2021)

Table Global Biosimilar Drug Sales Market Share by Player (2019-2021)

Figure Global Biosimilar Drug Sales Market Share by Player in 2021

Table Global Biosimilar Drug Revenue (Million $) by Player (2019-2021)

Table Global Biosimilar Drug Revenue Market Share by Player (2019-2021)

Figure Global Biosimilar Drug Revenue Market Share by Player in 2021

Table Global Biosimilar Drug Average Price by Player (2019-2021)

Figure Global Biosimilar Drug Average Price by Player in 2021

Figure Global Biosimilar Drug Players Competition Situation – Top 5 Players’ Revenue Market Share in 2019

Figure Global Biosimilar Drug Players Competition Trends – Top 5 Players’ Revenue Market Share in 2021

Figure Example of Injection

Figure Global Injection Revenue (Million $) and Growth Rate (2016-2021)

Figure Example of Tablets

Figure Global Tablets Revenue (Million $) and Growth Rate (2016-2021)

Figure Example of Other Types

Figure Global Other Types Revenue (Million $) and Growth Rate (2016-2021)

Table Global Biosimilar Drug Sales by Type (2016-2021)

Table Global Biosimilar Drug Sales Market Share by Type (2016-2021)

Figure Global Biosimilar Drug Sales Market Share by Type in 2021

Table Global Biosimilar Drug Revenue (Million $) by Type (2016-2021)

Table Global Biosimilar Drug Revenue Market Share by Type (2016-2021)

Figure Global Biosimilar Drug Revenue Market Share by Type in 2021

Table Global Biosimilar Drug Average Price by Type (2016-2021)

Figure Global Biosimilar Drug Average Price by Type in 2021

Table Leading Players of Biosimilar Drug by Type in 2021

Figure Example of Ankylosing Spondylitis

Figure Global Biosimilar Drug for Ankylosing Spondylitis Revenue (Million $) and Growth Rate (2016-2021)

Figure Example of Tumor

Figure Global Biosimilar Drug for Tumor Revenue (Million $) and Growth Rate (2016-2021)

Figure Example of Rheumatoid Arthrtis

Figure Global Biosimilar Drug for Rheumatoid Arthrtis Revenue (Million $) and Growth Rate (2016-2021)

Figure Example of Cardiovascular

Figure Global Biosimilar Drug for Cardiovascular Revenue (Million $) and Growth Rate (2016-2021)

Figure Example of Other Application

Figure Global Biosimilar Drug for Other Application Revenue (Million $) and Growth Rate (2016-2021)

Table Global Biosimilar Drug Sales by Application (2016-2021)

Table Global Biosimilar Drug Sales Market Share by Application (2016-2021)

Figure Global Biosimilar Drug Sales Market Share by Application in 2021

Table Leading Consumers of Biosimilar Drug by Application in 2021

Figure Example of Direct Channel

Figure Global Biosimilar Drug for Direct Channel Revenue (Million $) and Growth Rate (2016-2021)

Figure Example of Distribution Channel

Figure Global Biosimilar Drug for Distribution Channel Revenue (Million $) and Growth Rate (2016-2021)

Table Global Biosimilar Drug Revenue by Sales Channel (2016-2021)

Table Global Biosimilar Drug Revenue Market Share by Sales Channel (2016-2021)

Figure Global Biosimilar Drug Revenue Market Share by Sales Channel in 2021

Table Leading Distributors/Dealers of Biosimilar Drug by Sales Channel in 2021

Table Global Biosimilar Drug Market Size and CAGR by Region (2016-2030)

Table Global Biosimilar Drug Sales by Region (2016-2021)

Table Global Biosimilar Drug Sales Market Share by Region (2016-2021)

Figure Global Biosimilar Drug Sales Market Share by Region in 2021

Table Global Biosimilar Drug Revenue (Million $) by Region (2016-2021)

Table Global Biosimilar Drug Revenue Market Share by Region (2016-2021)

Figure Global Biosimilar Drug Revenue Market Share by Region in 2021

Table North America Biosimilar Drug Sales by Country (2016-2021)

Figure North America Biosimilar Drug Sales Market Share by Country (2016-2021)

Table North America Biosimilar Drug Revenue by Country (2016-2021)

Figure North America Biosimilar Drug Revenue Market Share by Country (2016-2021)

Figure North America Biosimilar Drug Market Share by Type in 2021

Figure North America Biosimilar Drug Market Share by Application in 2021

Figure United States Biosimilar Drug Sales and Growth Rate (2016-2021)

Figure United States Biosimilar Drug Revenue (Million $) and Growth Rate (2016-2021)

Figure Canada Biosimilar Drug Sales and Growth Rate (2016-2021)

Figure Canada Biosimilar Drug Revenue (Million $) and Growth Rate (2016-2021)

Figure Mexico Biosimilar Drug Sales and Growth Rate (2016-2021)

Figure Mexico Biosimilar Drug Revenue (Million $) and Growth Rate (2016-2021)

Table Europe Biosimilar Drug Sales by Country (2016-2021)

Figure Europe Biosimilar Drug Sales Market Share by Country (2016-2021)

Table Europe Biosimilar Drug Revenue by Country (2016-2021)

Figure Europe Biosimilar Drug Revenue Market Share by Country (2016-2021)

Figure Europe Biosimilar Drug Market Share by Type in 2021

Figure Europe Biosimilar Drug Market Share by Application in 2021

Figure Germany Biosimilar Drug Sales and Growth Rate (2016-2021)

Figure Germany Biosimilar Drug Revenue (Million $) and Growth Rate (2016-2021)

Figure UK Biosimilar Drug Sales and Growth Rate (2016-2021)

Figure UK Biosimilar Drug Revenue (Million $) and Growth Rate (2016-2021)

Figure France Biosimilar Drug Sales and Growth Rate (2016-2021)

Figure France Biosimilar Drug Revenue (Million $) and Growth Rate (2016-2021)

Figure Italy Biosimilar Drug Sales and Growth Rate (2016-2021)

Figure Italy Biosimilar Drug Revenue (Million $) and Growth Rate (2016-2021)

Figure Russia Biosimilar Drug Sales and Growth Rate (2016-2021)

Figure Russia Biosimilar Drug Revenue (Million $) and Growth Rate (2016-2021)

Figure Spain Biosimilar Drug Sales and Growth Rate (2016-2021)

Figure Spain Biosimilar Drug Revenue (Million $) and Growth Rate (2016-2021)

Table Asia-Pacific Biosimilar Drug Sales by Country (2016-2021)

Figure Asia-Pacific Biosimilar Drug Sales Market Share by Country (2016-2021)

Table Asia-Pacific Biosimilar Drug Revenue by Country (2016-2021)

Figure Asia-Pacific Biosimilar Drug Revenue Market Share by Country (2016-2021)

Figure Asia-Pacific Biosimilar Drug Market Share by Type in 2021

Figure Asia-Pacific Biosimilar Drug Market Share by Application in 2021

Figure China Biosimilar Drug Sales and Growth Rate (2016-2021)

Figure China Biosimilar Drug Revenue (Million $) and Growth Rate (2016-2021)

Figure Japan Biosimilar Drug Sales and Growth Rate (2016-2021)

Figure Japan Biosimilar Drug Revenue (Million $) and Growth Rate (2016-2021)

Figure Korea Biosimilar Drug Sales and Growth Rate (2016-2021)

Figure Korea Biosimilar Drug Revenue (Million $) and Growth Rate (2016-2021)

Figure India Biosimilar Drug Sales and Growth Rate (2016-2021)

Figure India Biosimilar Drug Revenue (Million $) and Growth Rate (2016-2021)

Figure Southeast Asia Biosimilar Drug Sales and Growth Rate (2016-2021)

Figure Southeast Asia Biosimilar Drug Revenue (Million $) and Growth Rate (2016-2021)

Figure Australia Biosimilar Drug Sales and Growth Rate (2016-2021)

Figure Australia Biosimilar Drug Revenue (Million $) and Growth Rate (2016-2021)

Table South America Biosimilar Drug Sales by Country (2016-2021)

Figure South America Biosimilar Drug Sales Market Share by Country (2016-2021)

Table South America Biosimilar Drug Revenue by Country (2016-2021)

Figure South America Biosimilar Drug Revenue Market Share by Country (2016-2021)

Figure South America Biosimilar Drug Market Share by Type in 2021

Figure South America Biosimilar Drug Market Share by Application in 2021

Figure Brazil Biosimilar Drug Sales and Growth Rate (2016-2021)

Figure Brazil Biosimilar Drug Revenue (Million $) and Growth Rate (2016-2021)

Figure Argentina Biosimilar Drug Sales and Growth Rate (2016-2021)

Figure Argentina Biosimilar Drug Revenue (Million $) and Growth Rate (2016-2021)

Figure Colombia Biosimilar Drug Sales and Growth Rate (2016-2021)

Figure Colombia Biosimilar Drug Revenue (Million $) and Growth Rate (2016-2021)

Table Middle East & Africa Biosimilar Drug Sales by Country (2016-2021)

Figure Middle East & Africa Biosimilar Drug Sales Market Share by Country (2016-2021)

Table Middle East & Africa Biosimilar Drug Revenue by Country (2016-2021)

Figure Middle East & Africa Biosimilar Drug Revenue Market Share by Country (2016-2021)

Figure Middle East & Africa Biosimilar Drug Market Share by Type in 2021

Figure Middle East & Africa Biosimilar Drug Market Share by Application in 2021

Figure UAE Biosimilar Drug Sales and Growth Rate (2016-2021)

Figure UAE Biosimilar Drug Revenue (Million $) and Growth Rate (2016-2021)

Figure Saudi Arabia Biosimilar Drug Sales and Growth Rate (2016-2021)

Figure Saudi Arabia Biosimilar Drug Revenue (Million $) and Growth Rate (2016-2021)

Figure South Africa Biosimilar Drug Sales and Growth Rate (2016-2021)

Figure South Africa Biosimilar Drug Revenue (Million $) and Growth Rate (2016-2021)

Table Company Snapshot of Roche

Table Biosimilar Drug Introduction of Roche

Table Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share of Roche (2019-2021)

Table Industrial Chain of Biosimilar Drug

Table Manufacturing Cost Structure of Biosimilar Drug

Table General Manufacturing Process of Biosimilar Drug

Table Leading Distributors/Dealers of Biosimilar Drug

Table Leading Consumers of Biosimilar Drug

Figure Global Biosimilar Drug Sales and Growth Rate Forecast (2022-2030)

Figure Global Biosimilar Drug Revenue and Growth Rate Forecast (2022-2030)

Table Global Biosimilar Drug Market Size and CAGR Forecast by Region (2022-2030)

Table Global Biosimilar Drug Market Size and CAGR Forecast by Type (2022-2030)

Table Global Biosimilar Drug Market Size and CAGR Forecast by Application (2022-2030)

Table Global Biosimilar Drug Market Size and CAGR Forecast by Sales Channel (2022-2030)

If you have any special requirements, please let us know and we will offer you the report as you want.

Please share youre basic details, to recieve the report sample

If you have any special requirements, please let us know and we will offer you the report as you want.

Our Clients

dropbox
kodak
honeywell
philips
nestle
Hanwha
Compass-Minerals
Elanco
Honda-Europe
Courant.Biz | Powered By SAIME DIGITAL TECHNOLOGIES PVT. LTD. | © 2020